文献速递血管炎

免疫检查点分子在ANCA相关性血管炎中的表现

Immune checkpoint molecules performance in ANCA vasculitis.
PubMed 文献 · RMD Open · 2024-11-13

该研究纳入本中心88例ANCA相关性血管炎(AAV)患者作为发现队列(急性期42例、缓解期46例),并纳入另一机构30例患者进行外部验证(急性期16例、缓解期14例),检测血清、尿液及外周血单个核细胞(PBMC)中PD-1、PD-L1、PD-L2浓度及肾脏活检中PD-1/PD-L1表达。结果显示尿液和PBMC中PD-1轴分子在AAV中降低,而血清中升高,急性期与缓解期存在差异,验证队列证实了血清和尿液发现。作者提出PD-1轴可能作为疾病活动性的新生物标志物。

要点

  • AAV患者尿PD-1和尿PD-L2浓度低于健康对照(p<0.0001,p=0.0075)。
  • 急性期AAV患者尿PD-L2水平低于缓解期患者(p=0.036)。
  • AAV患者血清PD-1和PD-L1浓度高于健康对照(p=0.007,p<0.0001),急性期血清PD-1高于缓解期(p=0.0051)。

核心结论

  • 尿液、细胞培养上清和組織学结果提示免疫检查点通路在急性期AAV中被废除、在缓解期恢复,有助于理解PD-1轴在AAV中的作用,并提出其作为疾病活动性新生物标志物的可能。

研究设计与样本

  • 研究纳入本中心88例AAV患者作为发现队列(急性期42例、缓解期46例),并纳入另一机构30例患者进行外部验证(急性期16例、缓解期14例)。
  • 收集血清、尿液和外周血单个核细胞(PBMC),在有或无MPO/PR3抗原刺激条件下体外研究淋巴细胞产生免疫检查点分子。
  • 采用多重检测法测定AAV患者和健康对照血清、尿液及细胞培养上清中PD-1、PD-L1和PD-L2浓度,并分析6例诊断性肾脏活检中PD-1和PD-L1表达。

主要发现

  • AAV患者尿PD-1和尿PD-L2浓度低于健康对照(p<0.0001,p=0.0075)。
  • 急性期AAV患者尿PD-L2水平低于缓解期患者(p=0.036)。
  • AAV患者PBMC产生的PD-1低于健康对照(刺激组p=0.04,未刺激组p=0.0074)。
  • 有炎症性肾脏病变的患者较硬化性病变患者PD-1阳性间质细胞/染色强度更少。
  • AAV患者血清PD-1和血清PD-L1浓度高于健康对照(p=0.007,p<0.0001),急性期患者血清PD-1水平高于缓解期患者(p=0.0051);血清和尿液发现均在验证队列中得到证实。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The PD-1 axis promotes protection against autoimmunity. Immune checkpoint (IC) molecules performance in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) remains unknown. This study aims to assess the IC pathway's role in the AAV's pathophysiology. METHODS: We recruited 88 AAV from our centre as a discovery cohort (acute=42, remission=46) and 30 patients from another institution for external validation (acute=16, remission=14).Serum, urine and peripheral blood mononuclear cells (PBMCs) were collected. In vitro IC molecules production by lymphocytes was studied with and without MPO/PR3 antigen stimulus. Cell culture supernatant (SN) was obtained by centrifugation. PD-1, PD-L1 and PD-L2 concentrations were assessed in serum (s), urine (u) and SN of AAV and healthy controls (HC) using a multiplex assay. PD-1 and PD-L1's expression was analysed in six diagnostic kidney biopsies. RESULTS: uPD-1 and uPD-L2's concentration was lower in AAV than HC (p<0.0001, p=0.0075). Acute patients exhibited lower uPD-L2 levels compared with those in remission (p=0.036). Similarly, PBMCs showed reduced PD-1 production than HC (stimulated group p=0.04, unstimulated p=0.0074). Furthermore, patients with inflammatory renal lesions had fewer PD-1-positive interstitial cells/staining intensity compared with those with sclerotic lesions. Contradictorily, sPD-1 and sPD-L1's concentration was higher in AAV than HC (p=0.007, p<0.0001) with acute patients exhibiting elevated sPD-1 levels compared with those in remission (p=0.0051). Serum and urine findings were confirmed in the validation cohort. CONCLUSIONS: Results in urine, SN and histology suggest IC pathway abolition during acute disease restored in remission and contribute to understand PD-1 axis's role in AAV proposing it as a new biomarker of disease activity.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Anton-Pampols P, Martinez Valenzuela L, Fernandez Lorente L, et al. Immune checkpoint molecules performance in ANCA vasculitis. RMD Open. 2024. PMID: 39537557. doi:10.1136/rmdopen-2024-004660

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。